NK and Dendritic Cell Generation from Hemangioblasts
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for generating natural killer (NK) cells and dendritic cells from hemangioblasts are inefficient and lack reproducibility, particularly in serum- and stromal-free conditions, limiting their immunotherapeutic potential.
Innovation Solution
A method involving the culture of hemangioblasts on methylcellulose with specific cytokine mixtures, followed by liquid media cultivation, to differentiate NK cells and dendritic cells, utilizing cytokines such as IL2, IL3, IL6, IL7, IL15, SCF, and FL, and additional cytokines like IL4 and GM-CSF, to achieve CD56+ and CD16+ NK cells and mature dendritic cells.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If hemangioblasts are cultured under serum-free and stromal-free conditions, then the method achieves simplicity and reproducibility, but the efficiency of generating NK cells and dendritic cells is insufficient
Solution Approach 1:
The patent optimizes cytokine concentrations and culture conditions to achieve efficient cell generation under serum-free and stromal-free conditions. Specific cytokine mixtures (IL-2, IL-3, IL-6, IL-7, IL-15, SCF, FL) are used at defined concentrations to drive hematopoietic differentiation while maintaining simplicity and reproducibility of the culture system.
2Reliability
If specific cytokine mixtures are used to enhance differentiation efficiency, then the immunotherapeutic potential is improved, but the complexity of the culture system increases
Solution Approach 1:
The patent divides the differentiation process into distinct stages with specific cytokine combinations. The first culture uses cytokines (IL-2, IL-3, IL-6, IL-7, IL-15, SCF, FL) to generate hematopoietic progenitors, followed by a second culture stage with different cytokines (IL-4, GM-CSF) to generate NK cells and dendritic cells. This segmented approach enhances reliability while managing system complexity through staged optimization.
Data Source
AI summary
This invention provides methods of generating natural killer (NK) cells and dendritic cells (DCs). The methods utilize human hemangioblasts as intermediate cells to generate the NK cells and DCs. In various embodiments, the methods do not require the use of stromal feeder layers.